nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—CYP1A2—Carmustine—melanoma	0.233	0.27	CbGbCtD
Pyrazinamide—CYP1A2—Vemurafenib—melanoma	0.184	0.213	CbGbCtD
Pyrazinamide—CYP3A4—Temozolomide—melanoma	0.176	0.204	CbGbCtD
Pyrazinamide—CYP1A2—Dacarbazine—melanoma	0.141	0.163	CbGbCtD
Pyrazinamide—CYP3A4—Vemurafenib—melanoma	0.0963	0.112	CbGbCtD
Pyrazinamide—CYP3A4—Docetaxel—melanoma	0.0331	0.0383	CbGbCtD
Pyrazinamide—Clotting—Temozolomide—melanoma	0.00655	0.0522	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Vemurafenib—melanoma	0.00593	0.0472	CcSEcCtD
Pyrazinamide—Rash maculo-papular—Vemurafenib—melanoma	0.00416	0.0331	CcSEcCtD
Pyrazinamide—Photosensitivity—Vemurafenib—melanoma	0.00378	0.0301	CcSEcCtD
Pyrazinamide—Hepatomegaly—Dactinomycin—melanoma	0.00365	0.0291	CcSEcCtD
Pyrazinamide—Digestion impaired—Temozolomide—melanoma	0.0035	0.0279	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Dactinomycin—melanoma	0.00335	0.0267	CcSEcCtD
Pyrazinamide—Coagulopathy—Dactinomycin—melanoma	0.00332	0.0265	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Carmustine—melanoma	0.00313	0.025	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Temozolomide—melanoma	0.00303	0.0241	CcSEcCtD
Pyrazinamide—Coagulopathy—Temozolomide—melanoma	0.003	0.0239	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Vemurafenib—melanoma	0.00262	0.0209	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Docetaxel—melanoma	0.00201	0.016	CcSEcCtD
Pyrazinamide—Arthralgia—Vemurafenib—melanoma	0.0017	0.0136	CcSEcCtD
Pyrazinamide—Myalgia—Vemurafenib—melanoma	0.0017	0.0136	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00149	0.0118	CcSEcCtD
Pyrazinamide—Decreased appetite—Vemurafenib—melanoma	0.00142	0.0113	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Vemurafenib—melanoma	0.00141	0.0112	CcSEcCtD
Pyrazinamide—Dysuria—Temozolomide—melanoma	0.00137	0.0109	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Temozolomide—melanoma	0.00134	0.0107	CcSEcCtD
Pyrazinamide—Hepatitis—Dactinomycin—melanoma	0.0013	0.0103	CcSEcCtD
Pyrazinamide—Body temperature increased—Vemurafenib—melanoma	0.00129	0.0103	CcSEcCtD
Pyrazinamide—Hypersensitivity—Vemurafenib—melanoma	0.0012	0.00958	CcSEcCtD
Pyrazinamide—Hepatitis—Temozolomide—melanoma	0.00117	0.00935	CcSEcCtD
Pyrazinamide—Pruritus—Vemurafenib—melanoma	0.00116	0.0092	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Bleomycin—melanoma	0.00112	0.00896	CcSEcCtD
Pyrazinamide—Malaise—Bleomycin—melanoma	0.00109	0.0087	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Dactinomycin—melanoma	0.00105	0.00835	CcSEcCtD
Pyrazinamide—Vomiting—Vemurafenib—melanoma	0.00104	0.00827	CcSEcCtD
Pyrazinamide—Myalgia—Bleomycin—melanoma	0.00103	0.00822	CcSEcCtD
Pyrazinamide—Rash—Vemurafenib—melanoma	0.00103	0.0082	CcSEcCtD
Pyrazinamide—Dermatitis—Vemurafenib—melanoma	0.00103	0.00819	CcSEcCtD
Pyrazinamide—Discomfort—Bleomycin—melanoma	0.00102	0.00812	CcSEcCtD
Pyrazinamide—Malaise—Dactinomycin—melanoma	0.00102	0.00812	CcSEcCtD
Pyrazinamide—Nausea—Vemurafenib—melanoma	0.00097	0.00772	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Bleomycin—melanoma	0.000969	0.00771	CcSEcCtD
Pyrazinamide—Myalgia—Dactinomycin—melanoma	0.000962	0.00766	CcSEcCtD
Pyrazinamide—Discomfort—Dactinomycin—melanoma	0.000951	0.00757	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Temozolomide—melanoma	0.000949	0.00756	CcSEcCtD
Pyrazinamide—Anorexia—Bleomycin—melanoma	0.000943	0.00751	CcSEcCtD
Pyrazinamide—Malaise—Temozolomide—melanoma	0.000922	0.00734	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Dactinomycin—melanoma	0.000903	0.00719	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Bleomycin—melanoma	0.000901	0.00718	CcSEcCtD
Pyrazinamide—Myalgia—Carmustine—melanoma	0.000901	0.00717	CcSEcCtD
Pyrazinamide—Anorexia—Dactinomycin—melanoma	0.000879	0.007	CcSEcCtD
Pyrazinamide—Myalgia—Temozolomide—melanoma	0.00087	0.00693	CcSEcCtD
Pyrazinamide—Arthralgia—Temozolomide—melanoma	0.00087	0.00693	CcSEcCtD
Pyrazinamide—Discomfort—Temozolomide—melanoma	0.00086	0.00685	CcSEcCtD
Pyrazinamide—Decreased appetite—Bleomycin—melanoma	0.00086	0.00685	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Carmustine—melanoma	0.000845	0.00673	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000841	0.00669	CcSEcCtD
Pyrazinamide—Anorexia—Carmustine—melanoma	0.000823	0.00655	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Temozolomide—melanoma	0.000817	0.00651	CcSEcCtD
Pyrazinamide—Feeling abnormal—Bleomycin—melanoma	0.000815	0.00649	CcSEcCtD
Pyrazinamide—Decreased appetite—Dactinomycin—melanoma	0.000802	0.00639	CcSEcCtD
Pyrazinamide—Anorexia—Temozolomide—melanoma	0.000795	0.00633	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Carmustine—melanoma	0.000787	0.00627	CcSEcCtD
Pyrazinamide—Urticaria—Bleomycin—melanoma	0.000786	0.00626	CcSEcCtD
Pyrazinamide—Body temperature increased—Bleomycin—melanoma	0.000782	0.00623	CcSEcCtD
Pyrazinamide—Hepatitis—Docetaxel—melanoma	0.000781	0.00622	CcSEcCtD
Pyrazinamide—Feeling abnormal—Dactinomycin—melanoma	0.00076	0.00605	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Temozolomide—melanoma	0.00076	0.00605	CcSEcCtD
Pyrazinamide—Decreased appetite—Carmustine—melanoma	0.000751	0.00598	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Carmustine—melanoma	0.000745	0.00594	CcSEcCtD
Pyrazinamide—Dyspepsia—Temozolomide—melanoma	0.000735	0.00585	CcSEcCtD
Pyrazinamide—Body temperature increased—Dactinomycin—melanoma	0.000729	0.00581	CcSEcCtD
Pyrazinamide—Hypersensitivity—Bleomycin—melanoma	0.000729	0.0058	CcSEcCtD
Pyrazinamide—Decreased appetite—Temozolomide—melanoma	0.000725	0.00578	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Temozolomide—melanoma	0.00072	0.00574	CcSEcCtD
Pyrazinamide—Feeling abnormal—Carmustine—melanoma	0.000712	0.00567	CcSEcCtD
Pyrazinamide—Pruritus—Bleomycin—melanoma	0.0007	0.00557	CcSEcCtD
Pyrazinamide—Feeling abnormal—Temozolomide—melanoma	0.000688	0.00548	CcSEcCtD
Pyrazinamide—Body temperature increased—Carmustine—melanoma	0.000683	0.00544	CcSEcCtD
Pyrazinamide—Hypersensitivity—Dactinomycin—melanoma	0.00068	0.00541	CcSEcCtD
Pyrazinamide—Urticaria—Temozolomide—melanoma	0.000663	0.00528	CcSEcCtD
Pyrazinamide—Body temperature increased—Temozolomide—melanoma	0.00066	0.00525	CcSEcCtD
Pyrazinamide—Hypersensitivity—Carmustine—melanoma	0.000636	0.00507	CcSEcCtD
Pyrazinamide—Vomiting—Bleomycin—melanoma	0.000629	0.00501	CcSEcCtD
Pyrazinamide—Rash—Bleomycin—melanoma	0.000624	0.00497	CcSEcCtD
Pyrazinamide—Dermatitis—Bleomycin—melanoma	0.000623	0.00496	CcSEcCtD
Pyrazinamide—Hypersensitivity—Temozolomide—melanoma	0.000615	0.0049	CcSEcCtD
Pyrazinamide—Pruritus—Temozolomide—melanoma	0.00059	0.0047	CcSEcCtD
Pyrazinamide—Nausea—Bleomycin—melanoma	0.000588	0.00468	CcSEcCtD
Pyrazinamide—Vomiting—Dactinomycin—melanoma	0.000587	0.00467	CcSEcCtD
Pyrazinamide—Rash—Dactinomycin—melanoma	0.000582	0.00463	CcSEcCtD
Pyrazinamide—Arthralgia—Docetaxel—melanoma	0.000579	0.00461	CcSEcCtD
Pyrazinamide—Myalgia—Docetaxel—melanoma	0.000579	0.00461	CcSEcCtD
Pyrazinamide—Vomiting—Carmustine—melanoma	0.000549	0.00437	CcSEcCtD
Pyrazinamide—Nausea—Dactinomycin—melanoma	0.000548	0.00436	CcSEcCtD
Pyrazinamide—Rash—Carmustine—melanoma	0.000544	0.00434	CcSEcCtD
Pyrazinamide—Dermatitis—Carmustine—melanoma	0.000544	0.00433	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Docetaxel—melanoma	0.000543	0.00433	CcSEcCtD
Pyrazinamide—Vomiting—Temozolomide—melanoma	0.000531	0.00423	CcSEcCtD
Pyrazinamide—Anorexia—Docetaxel—melanoma	0.000529	0.00421	CcSEcCtD
Pyrazinamide—Rash—Temozolomide—melanoma	0.000526	0.00419	CcSEcCtD
Pyrazinamide—Dermatitis—Temozolomide—melanoma	0.000526	0.00419	CcSEcCtD
Pyrazinamide—Nausea—Carmustine—melanoma	0.000513	0.00408	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000506	0.00403	CcSEcCtD
Pyrazinamide—Nausea—Temozolomide—melanoma	0.000496	0.00395	CcSEcCtD
Pyrazinamide—Dyspepsia—Docetaxel—melanoma	0.000488	0.00389	CcSEcCtD
Pyrazinamide—Decreased appetite—Docetaxel—melanoma	0.000482	0.00384	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Docetaxel—melanoma	0.000479	0.00382	CcSEcCtD
Pyrazinamide—Feeling abnormal—Docetaxel—melanoma	0.000457	0.00364	CcSEcCtD
Pyrazinamide—Body temperature increased—Docetaxel—melanoma	0.000439	0.00349	CcSEcCtD
Pyrazinamide—Hypersensitivity—Docetaxel—melanoma	0.000409	0.00326	CcSEcCtD
Pyrazinamide—Pruritus—Docetaxel—melanoma	0.000393	0.00313	CcSEcCtD
Pyrazinamide—Vomiting—Docetaxel—melanoma	0.000353	0.00281	CcSEcCtD
Pyrazinamide—Rash—Docetaxel—melanoma	0.00035	0.00279	CcSEcCtD
Pyrazinamide—Dermatitis—Docetaxel—melanoma	0.00035	0.00278	CcSEcCtD
Pyrazinamide—Nausea—Docetaxel—melanoma	0.00033	0.00263	CcSEcCtD
Pyrazinamide—AOX1—Metabolism—PIP4K2A—melanoma	3.97e-05	0.00335	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—SLC6A11—melanoma	3.97e-05	0.00335	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CUBN—melanoma	3.96e-05	0.00334	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PLCB4—melanoma	3.93e-05	0.00332	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—MTAP—melanoma	3.86e-05	0.00326	CbGpPWpGaD
Pyrazinamide—XDH—Selenium Micronutrient Network—IL6—melanoma	3.84e-05	0.00324	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CSPG4—melanoma	3.82e-05	0.00323	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RPS3—melanoma	3.76e-05	0.00318	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—SKI—melanoma	3.7e-05	0.00313	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—SLC6A11—melanoma	3.69e-05	0.00312	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIP4K2A—melanoma	3.69e-05	0.00312	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—melanoma	3.68e-05	0.00311	CbGpPWpGaD
Pyrazinamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	3.62e-05	0.00306	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—MTAP—melanoma	3.59e-05	0.00303	CbGpPWpGaD
Pyrazinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	3.45e-05	0.00291	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—LUM—melanoma	3.44e-05	0.00291	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PHGDH—melanoma	3.44e-05	0.00291	CbGpPWpGaD
Pyrazinamide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	3.4e-05	0.00287	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—HPSE—melanoma	3.38e-05	0.00285	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	3.36e-05	0.00284	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	3.32e-05	0.0028	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CUBN—melanoma	3.31e-05	0.0028	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—SDHD—melanoma	3.2e-05	0.0027	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—BSG—melanoma	3.2e-05	0.0027	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PHGDH—melanoma	3.2e-05	0.0027	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—LUM—melanoma	3.2e-05	0.0027	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CSPG4—melanoma	3.2e-05	0.0027	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—HPSE—melanoma	3.14e-05	0.00265	CbGpPWpGaD
Pyrazinamide—CYP1A2—Melatonin metabolism and effects—NFKB1—melanoma	3.12e-05	0.00264	CbGpPWpGaD
Pyrazinamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	3.11e-05	0.00263	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GPAM—melanoma	3.1e-05	0.00262	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CUBN—melanoma	3.08e-05	0.0026	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HDAC6—melanoma	3.06e-05	0.00258	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—RB1—melanoma	3.03e-05	0.00256	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—SDHD—melanoma	2.98e-05	0.00251	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CSPG4—melanoma	2.98e-05	0.00251	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—BSG—melanoma	2.98e-05	0.00251	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—melanoma	2.9e-05	0.00245	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NPPA—melanoma	2.9e-05	0.00245	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GPAM—melanoma	2.88e-05	0.00243	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ACER3—melanoma	2.88e-05	0.00243	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—VCAN—melanoma	2.83e-05	0.00239	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—WNT5A—melanoma	2.81e-05	0.00237	CbGpPWpGaD
Pyrazinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	2.79e-05	0.00236	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PLA2G6—melanoma	2.64e-05	0.00223	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	2.6e-05	0.00219	CbGpPWpGaD
Pyrazinamide—CYP1A2—Tryptophan metabolism—MDM2—melanoma	2.58e-05	0.00218	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—melanoma	2.49e-05	0.0021	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PLA2G6—melanoma	2.45e-05	0.00207	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—VCAN—melanoma	2.37e-05	0.002	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—melanoma	2.36e-05	0.00199	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	2.36e-05	0.00199	CbGpPWpGaD
Pyrazinamide—CYP1A2—Arachidonic acid metabolism—PTGS2—melanoma	2.33e-05	0.00197	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	2.31e-05	0.00195	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP17A1—melanoma	2.28e-05	0.00193	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP17A1—melanoma	2.25e-05	0.0019	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—GAB2—melanoma	2.25e-05	0.0019	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FASN—melanoma	2.2e-05	0.00186	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—VCAN—melanoma	2.2e-05	0.00186	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—melanoma	2.18e-05	0.00184	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—melanoma	2.16e-05	0.00182	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FOXO4—melanoma	2.12e-05	0.00179	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HDAC2—melanoma	2.12e-05	0.00179	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CXCR4—melanoma	2.12e-05	0.00179	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CD44—melanoma	2.09e-05	0.00177	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP17A1—melanoma	2e-05	0.00169	CbGpPWpGaD
Pyrazinamide—CYP3A4—Tryptophan metabolism—MDM2—melanoma	1.99e-05	0.00168	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—melanoma	1.96e-05	0.00166	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—melanoma	1.94e-05	0.00164	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT3—melanoma	1.93e-05	0.00163	CbGpPWpGaD
Pyrazinamide—CYP1A2—Biological oxidations—CYP1B1—melanoma	1.92e-05	0.00162	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metapathway biotransformation—CYP1B1—melanoma	1.9e-05	0.0016	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GNA11—melanoma	1.89e-05	0.00159	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP17A1—melanoma	1.86e-05	0.00157	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—FASN—melanoma	1.85e-05	0.00156	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—SLC5A5—melanoma	1.82e-05	0.00153	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—melanoma	1.8e-05	0.00152	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—melanoma	1.76e-05	0.00149	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—melanoma	1.76e-05	0.00149	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	1.76e-05	0.00149	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP17A1—melanoma	1.76e-05	0.00149	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—GNAQ—melanoma	1.75e-05	0.00148	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CD44—melanoma	1.75e-05	0.00148	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GNA11—melanoma	1.75e-05	0.00148	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	1.74e-05	0.00147	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	1.74e-05	0.00147	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—FASN—melanoma	1.72e-05	0.00145	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ERBB4—melanoma	1.71e-05	0.00144	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN2B—melanoma	1.69e-05	0.00143	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—SLC5A5—melanoma	1.69e-05	0.00143	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—CYP1B1—melanoma	1.68e-05	0.00142	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	1.68e-05	0.00142	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—melanoma	1.68e-05	0.00142	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—melanoma	1.67e-05	0.00141	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CD86—melanoma	1.64e-05	0.00138	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—GNAQ—melanoma	1.63e-05	0.00138	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CD44—melanoma	1.63e-05	0.00138	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGF1—melanoma	1.59e-05	0.00134	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—CYP1B1—melanoma	1.56e-05	0.00132	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PDGFRA—melanoma	1.54e-05	0.0013	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PRKCA—melanoma	1.52e-05	0.00128	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ERCC2—melanoma	1.51e-05	0.00127	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAP2K2—melanoma	1.49e-05	0.00126	CbGpPWpGaD
Pyrazinamide—CYP3A4—Biological oxidations—CYP1B1—melanoma	1.48e-05	0.00125	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	1.46e-05	0.00124	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CUBN—melanoma	1.46e-05	0.00123	CbGpPWpGaD
Pyrazinamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—melanoma	1.42e-05	0.0012	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—TERT—melanoma	1.41e-05	0.00119	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HLA-A—melanoma	1.41e-05	0.00119	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—RAC1—melanoma	1.41e-05	0.00119	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ABCB1—melanoma	1.38e-05	0.00117	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—GPAM—melanoma	1.36e-05	0.00115	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HIF1A—melanoma	1.35e-05	0.00114	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ABCB1—melanoma	1.29e-05	0.00109	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ACER3—melanoma	1.28e-05	0.00108	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PRKCA—melanoma	1.27e-05	0.00108	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ERCC2—melanoma	1.26e-05	0.00107	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOS2—melanoma	1.23e-05	0.00104	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NOTCH1—melanoma	1.22e-05	0.00103	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CD80—melanoma	1.19e-05	0.00101	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—KIT—melanoma	1.19e-05	0.00101	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—APC—melanoma	1.19e-05	0.00101	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PRKCA—melanoma	1.18e-05	0.001	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EGF—melanoma	1.18e-05	0.000995	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ERCC2—melanoma	1.18e-05	0.000992	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—UGT2B10—melanoma	1.17e-05	0.00099	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	1.16e-05	0.000977	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—BRAF—melanoma	1.12e-05	0.000946	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HS3ST5—melanoma	1.09e-05	0.00092	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAP2K1—melanoma	1.05e-05	0.000891	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CD—melanoma	1.05e-05	0.000885	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—FGF2—melanoma	1e-05	0.000847	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CG—melanoma	9.98e-06	0.000843	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ACER3—melanoma	9.89e-06	0.000835	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PPARG—melanoma	9.63e-06	0.000813	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MDM2—melanoma	9.39e-06	0.000793	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CG—melanoma	9.28e-06	0.000784	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—ERBB2—melanoma	9.26e-06	0.000781	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CB—melanoma	9.13e-06	0.000771	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CD4—melanoma	9.12e-06	0.00077	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTGS2—melanoma	9.05e-06	0.000764	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—UGT2B10—melanoma	9.05e-06	0.000764	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PPARG—melanoma	8.96e-06	0.000756	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CD—melanoma	8.78e-06	0.000741	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	8.77e-06	0.000741	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—ALB—melanoma	8.66e-06	0.000731	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN1B—melanoma	8.57e-06	0.000724	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HS3ST5—melanoma	8.41e-06	0.00071	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLCB4—melanoma	8.26e-06	0.000697	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CD—melanoma	8.16e-06	0.000689	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	8.11e-06	0.000685	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CTNNB1—melanoma	8.1e-06	0.000684	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—ALB—melanoma	8.05e-06	0.00068	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—CDKN1A—melanoma	7.91e-06	0.000668	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PTEN—melanoma	7.89e-06	0.000666	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIP4K2A—melanoma	7.77e-06	0.000656	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC6A11—melanoma	7.77e-06	0.000656	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CB—melanoma	7.65e-06	0.000646	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTGS2—melanoma	7.58e-06	0.00064	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—MTAP—melanoma	7.55e-06	0.000638	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	7.38e-06	0.000623	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CB—melanoma	7.11e-06	0.0006	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—STAT3—melanoma	7.06e-06	0.000596	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTGS2—melanoma	7.05e-06	0.000595	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—NRAS—melanoma	7.04e-06	0.000595	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAPK3—melanoma	6.74e-06	0.000569	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—LUM—melanoma	6.73e-06	0.000569	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PHGDH—melanoma	6.73e-06	0.000569	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PTEN—melanoma	6.61e-06	0.000558	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—HPSE—melanoma	6.6e-06	0.000558	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MYC—melanoma	6.56e-06	0.000554	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CUBN—melanoma	6.48e-06	0.000547	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—MAPK1—melanoma	6.42e-06	0.000542	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—EGFR—melanoma	6.42e-06	0.000542	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLCB4—melanoma	6.37e-06	0.000538	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—BSG—melanoma	6.26e-06	0.000529	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SDHD—melanoma	6.26e-06	0.000529	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CSPG4—melanoma	6.26e-06	0.000529	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PTEN—melanoma	6.14e-06	0.000519	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GPAM—melanoma	6.06e-06	0.000512	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—KRAS—melanoma	6.06e-06	0.000512	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC6A11—melanoma	5.99e-06	0.000506	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIP4K2A—melanoma	5.99e-06	0.000506	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—MTAP—melanoma	5.83e-06	0.000492	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—PIK3CA—melanoma	5.57e-06	0.00047	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PHGDH—melanoma	5.2e-06	0.000439	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—LUM—melanoma	5.2e-06	0.000439	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PLA2G6—melanoma	5.15e-06	0.000435	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—HRAS—melanoma	5.15e-06	0.000435	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—HPSE—melanoma	5.1e-06	0.00043	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CUBN—melanoma	5e-06	0.000422	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—IL6—melanoma	4.93e-06	0.000416	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SDHD—melanoma	4.83e-06	0.000408	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CSPG4—melanoma	4.83e-06	0.000408	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—BSG—melanoma	4.83e-06	0.000408	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GPAM—melanoma	4.68e-06	0.000395	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—PIK3CA—melanoma	4.66e-06	0.000394	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—VCAN—melanoma	4.63e-06	0.000391	CbGpPWpGaD
Pyrazinamide—AOX1—Disease—AKT1—melanoma	4.55e-06	0.000384	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.38e-06	0.00037	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—PIK3CA—melanoma	4.33e-06	0.000366	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.23e-06	0.000357	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PLA2G6—melanoma	3.98e-06	0.000336	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP17A1—melanoma	3.91e-06	0.00033	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.85e-06	0.000325	CbGpPWpGaD
Pyrazinamide—AOX1—Metabolism—AKT1—melanoma	3.81e-06	0.000322	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	3.8e-06	0.000321	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GNA11—melanoma	3.69e-06	0.000312	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—FASN—melanoma	3.61e-06	0.000305	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—VCAN—melanoma	3.57e-06	0.000302	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—SLC5A5—melanoma	3.55e-06	0.0003	CbGpPWpGaD
Pyrazinamide—XDH—Metabolism—AKT1—melanoma	3.54e-06	0.000299	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—GNAQ—melanoma	3.43e-06	0.00029	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CD44—melanoma	3.43e-06	0.00029	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.36e-06	0.000284	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.33e-06	0.000281	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—CYP1B1—melanoma	3.29e-06	0.000278	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP17A1—melanoma	3.02e-06	0.000255	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.9e-06	0.000245	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GNA11—melanoma	2.85e-06	0.00024	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—FASN—melanoma	2.79e-06	0.000235	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—SLC5A5—melanoma	2.74e-06	0.000231	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ABCB1—melanoma	2.71e-06	0.000229	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—GNAQ—melanoma	2.65e-06	0.000224	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CD44—melanoma	2.65e-06	0.000224	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—CYP1B1—melanoma	2.54e-06	0.000214	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PRKCA—melanoma	2.49e-06	0.00021	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ERCC2—melanoma	2.47e-06	0.000209	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ABCB1—melanoma	2.09e-06	0.000176	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.05e-06	0.000173	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CG—melanoma	1.95e-06	0.000165	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PRKCA—melanoma	1.92e-06	0.000162	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ERCC2—melanoma	1.91e-06	0.000161	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PPARG—melanoma	1.88e-06	0.000159	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CD—melanoma	1.72e-06	0.000145	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—ALB—melanoma	1.69e-06	0.000143	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CG—melanoma	1.51e-06	0.000127	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CB—melanoma	1.5e-06	0.000126	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTGS2—melanoma	1.48e-06	0.000125	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PPARG—melanoma	1.45e-06	0.000123	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CD—melanoma	1.32e-06	0.000112	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—ALB—melanoma	1.31e-06	0.00011	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PTEN—melanoma	1.29e-06	0.000109	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CB—melanoma	1.15e-06	9.75e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTGS2—melanoma	1.14e-06	9.66e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PTEN—melanoma	9.97e-07	8.42e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—PIK3CA—melanoma	9.12e-07	7.7e-05	CbGpPWpGaD
Pyrazinamide—CYP1A2—Metabolism—AKT1—melanoma	7.45e-07	6.29e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—PIK3CA—melanoma	7.04e-07	5.94e-05	CbGpPWpGaD
Pyrazinamide—CYP3A4—Metabolism—AKT1—melanoma	5.75e-07	4.85e-05	CbGpPWpGaD
